Elizabeth R. Gerstner

Phase II Study of Cediranib, an Oral Pan–Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor, in Patients With Recurrent Glioblastoma

Tracy T. Batchelor, Dan G. Duda, Emmanuelle di Tomaso et al. · Journal of Clinical Oncology · 2010 · 516 citations · Full text

Medicine, Oncology, Pharmacology +17

Detection of 2-Hydroxyglutarate in <i>IDH</i> -Mutated Glioma Patients by In Vivo Spectral-Editing and 2D Correlation Magnetic Resonance Spectroscopy

Ovidiu C. Andronesi, Grace S. Kim, Elizabeth R. Gerstner et al. · Science Translational Medicine · 2012 · 421 citations

Medicine, Biochemistry, Oncology +17

Intraventricular CARv3-TEAM-E T Cells in Recurrent Glioblastoma

Bryan D. Choi, Elizabeth R. Gerstner, Matthew J. Frigault et al. · New England Journal of Medicine · 2024 · 402 citations · Full text

Medicine, Immunology, Oncology +17

Residual Convolutional Neural Network for the Determination of <i>IDH</i> Status in Low- and High-Grade Gliomas from MR Imaging

Ken Chang, Harrison X. Bai, Hao Zhou et al. · Clinical Cancer Research · 2017 · 386 citations · Full text

Medicine, Oncology, Radiology +17

A Serologic Marker of Paraneoplastic Limbic and Brain-Stem Encephalitis in Patients with Testicular Cancer

Raymond Voltz, Sakir H. Gultekin, Myrna R. Rosenfeld et al. · New England Journal of Medicine · 1999 · 379 citations · Full text

Medicine, Neurology, Oncology +17